Preclinical assessment of dual CYP26[A1/B1] inhibitor, DX308, as an improved treatment for keratinization disorders

  • J. G.S. Veit
  • , Y. Poumay
  • , D. Mendes
  • , J. Kreitinger
  • , L. Walker
  • , A. Paquet
  • , C. Menigot
  • , F. Zolezzi
  • , A. S. Paller
  • , P. Diaz

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Fingerprint

Dive into the research topics of 'Preclinical assessment of dual CYP26[A1/B1] inhibitor, DX308, as an improved treatment for keratinization disorders'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science